Adverum Biotechnologies
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$117,165,000 and profit margin reached -3255%. Total operating expenses were $127,591,000.
Profit Margin
| 2014 | 572K | -25.40M | -4441.26% |
|---|---|---|---|
| 2015 | 2.31M | -47.45M | -2046.27% |
| 2016 | 1.45M | -113.74M | -7817.66% |
| 2017 | 1.84M | -56.14M | -3036.61% |
| 2018 | 1.61M | -72.62M | -4505.4% |
| 2019 | 250K | -64.48M | -25794.4% |
| 2020 | 0 | -117.50M | |
| 2021 | 7.5M | -145.54M | -1940.53% |
| 2022 | 0 | -154.53M | |
| 2023 | 3.6M | -117.16M | -3254.58% |
ADVM Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 3.6M | 0 | 7.5M | 0 | 250K | 1.61M | 1.84M | 1.45M | 2.31M | 572K |
Cost of revenue | 5.64M | 6.52M | 4.64M | 4.15M | 0 | 0 | 2.09M | 0 | 0 | 0 |
Gross profit | -2.04M | -6.52M | 2.85M | -4.15M | 250K | 1.61M | -247K | 1.45M | 2.31M | 572K |
Operating exp. | ||||||||||
Research and development | 77.67M | 99.27M | 89.18M | 73.30M | 40.41M | 50.13M | 39.83M | 31.67M | 25.46M | 16.97M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 127.59M | 157.13M | 153.62M | 117.95M | 68.79M | 74.69M | 60.69M | 56.02M | 47.56M | 24.97M |
Operating income | -123.79M | -157.13M | -146.12M | -117.95M | -68.54M | -78.08M | -58.84M | -115.28M | -47.82M | -24.40M |
Other income (expenses), net | 5.54M | 2.67M | 582K | 1.55M | 4.05M | -796K | 2.7M | -59.95M | -2.10M | -1.00M |
Income before tax | -118.24M | -154.46M | -145.54M | -116.39M | -64.48M | -73.87M | -56.14M | -114.52M | -47.45M | -25.40M |
Income tax expense | -1.07M | 74K | 0 | 1.11M | 0 | -1.25M | 0 | -775K | 1.76M | -162K |
Net income | -117.16M | -154.53M | -145.54M | -117.50M | -64.48M | -72.62M | -56.14M | -113.74M | -47.45M | -25.40M |
Earnings per share | ||||||||||
Basic EPS | -11.62 | -15.57 | -14.85 | -13.8 | -10.06 | -1.18 | -1.29 | -3.14 | -1.86 | -1.12 |
Diluted EPS | -11.62 | -15.57 | -14.85 | -13.8 | -10.06 | -1.18 | -1.29 | -3.14 | -1.84 | -1.12 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |